CMSC Monday, May 12 2008
CMSC Online



 
Home arrow CMSC Online arrow For CMSC Members arrow Annual Meetings
Annual Meeting - 2005 Program Print E-mail

2005 CMSC Annual Meeting
Navigating the World of Multiple Sclerosis
June 1-5
Walt Disney Dophin Hotel
Orlando, Florida

Note: All the presentations were converted to Adobe PDF. Copying and editing functions were disabled.

If you don"t have Adobe Reader, please go to www.adobe.com for a free download.

Fundamentals Lectures Symposium Workshops Mini-Courses Whitaker
  1. Fundamentals
    Fundamentals of MS Care and Management: Diagnosis to Rehabilitation
  2. Lectures
    • Research Lecture: Is MS a Neurodegenerative Disease?
      Bruce Trapp, PhD
    • LACTRIMS Lecture: Is MS Different in Latin America?
      Edgardo Cristiano, MD, FAAN
    • Presidential Lecture: The Potential for Remyelination in MS
      Cedric Raine, PhD, DSc
    • Angiogenesis and VEGF in EAE and MS: Is it Good, Bad or an Epiphenomenon?
      Joseph Frank, MD
  3. Symposia
    1. Diagnosing MS in 2005: Focus and Accuracy
    2. Rehabilitation in MS: The Evidence
    3. Pregnancy & MS: What We Know and What We Need to Learn
      • Pregnancy in MS
        Prof. Christian Confavreux, PhD
      • Reproductive Counselling
        Colleen Guimond, MSc, CGC
      • Disease Specific vs. Drug Specific Pregnancy Registries
        Vincent Armenti, MD, PhD
      • Where Do We Go From Here?
        A. Dessa Sadovnick, PhD
    4. Primary Progressive MS
      • Diagnosis and Prognosis
        Jerry Wolinsky, MD
      • MR Imaging and Pathological Correlates
        Daniel Pelletier, MD
      • Lessons Learned from Trials Past
        Emmanuelle Waubant, MD, PhD
      • Rituximab and other Ongoing Trials
        Kathleen Hawker, MD
    5. Neurocognitive Retraining in MS
      • Review of Neuropsychology of MS
        Cynthia Sullivan, PhD
      • Current Treatment Options for MS-Related Cognitive Dysfunction
        Jeffrey Wilken, PhD
      • Neurocognitive Retraining in MS
        Iris-Katharina Penner, MD
      • Research Against the Use of Cognitive Retraining in MS
        Mary Quig, PhD
      • Real World Issues in Cognitive Retraining
        Pat Bednarik, MS, CCC-SLP, MSCS
    6. Alternative Medicine and MS
      • Overview of Recent MS-Relevant Stduies
        Allen Bowling, MD, PhD
      • Vitamin D, Hygiene Hypothesis and MS
        John Fleming, MD
      • Placebo Effects: Clinical Perspectives and Mechanisms
        Barry Oken, MD
      • The Role of Placebo in MS Clinical Trials, Past and Future
        Ludwig Achim Kappos, MD
    7. Evolution of the MS Lesions
      • Understanding MS Through Pathology
        Samuel Ludwin, MD
      • The Evolution of the Immune Response in MS
        Anne Cross, MD
      • Humoral Immunity as a Biomarker in MS
        Claude Genain, MD
    8. The History of MS in 9 Acts
      Jock Murray, MD, FRCPC
      • The Framing of a Disease
      • From the Hand of God to the Mattress Greave - The Early Cases of MS 1400-1868
      • The Medical Descriptions of MS Before Charcot
      • The Contributions of Charcot and his Students
      • From Devine Intervention to Interferon - The History of Therapy in MS
      • The Search for Infection 1868-2005
      • From Coincidence to the Human Genome - The History of Genetics and MS
      • The Growing Role of the Public in MS
      • The Frame of the Disease in 2005
    9. Neuroprotection and Neurogeneration: New Avenues in the Treatement of MS
      • Neuroprotection and Neurogeneration: The Final Frontier
        Dennis Bourdette, MD
      • Sodium Channels, Glutamate Receptors and Neuroprotection: Old Drugs, New Uses
      • Stem Cell: Hope or Hype
        David Trisler, PhD
      • Remodeling the Brain After Injury: FMRI and Neuroplasticity
        Robert Shin, MD
    10. LACTRIMS
    11. Understanding and Treating Pediatric Multiple Sclerosis: Insights into Pathobiology and Therapeutics
  4. Workshops
    1. Powerpoint Intermediate
      Ric Goldenberg
    2. Sleep Disorders in MS
      David Brandes, MS, MD, FAAN; Rock Heyman, MD
    3. Dilemmas of Outcome Measures in Rehabilitation
      Sandra Brunham, MSc(PT), MSCS, Susan Forwell, MS, PhD(OT); Deborah Miller, PhD
    4. Legal Issues Related to Advanced Practice Nursing
      • When the Scales of Justice Tip
        Rebecca Berg Solano, Esq.
      • Encounters with the Legal System; Personal Perspectives
        Marie Namey, RN, MSN, MSCN; Linda Morgante, RN, MSN, CRRN, MSCN
    5. Approach to the Male Patient with Newly Diagnosed MS
      Teddi Scneider, APRN, FNP-C, CMSN
    6. Genomic Studies
      • MS Microarrays
        Bianca Weinstock-Guttman, MD
      • Identifying Genes Involved in MS
        Bernadette Kalman, MD, PhD
      • Proteomics: What Happens After DNA and RNA Synthesis
        Anthony Reder, MD
    7. Ethno-cultural Concerns in MS Care
    8. Powerpoint Advanced
      Ric Goldenrberg
    9. Mobility Aids and Assistive Devices
      • Ambulation and Transfer Aids
        Patricia Provance, PT, MSCS
      • Seating and Mobility for Comfort and Function
      • Assistive Devices
        Carrie Bruce, MA, CCC-SLp, ATP
    10. Advanced Practice MS Nursing: The Challenges of Progressive Disease Across Lifespan
    11. Cognitive Therapy: Practical Skills for Coping with Illness and Loss
      Jennifer Rodgers, PhD
    12. Nurturing your Children / Coping with Chronic Illness
      MS Coaliton; Hellen Egger, MD; Lara Krawchuck, MSW, LSW, MPH
    13. Immunology of MS
      Avertano Noronha, MD
    14. Caring for People
      • Living with Advanced MS: What do Patients and Their Caregivers Care About Most?
        David Grunewald, MD
      • Patient Preferences and Attitudes Regarding End of Life Decisions in MS
        James Bowen, MD
      • Key Issues in Symptom Management in Advanced MS
        Christopher Bever, MD
    15. How to Set-up Neurology-Based Infusion Capabilities: Rationale and Guidelines for the Administration of IV Therapies in the Treatment of MS
      • The Rationale and Decision-Making Process: Is it Feasible?
        Howard Rossman, DO
      • Considerations and Potential Pitfalls: Our Experience
        Sonda Lawson, MA, LLPC
      • Infusion Services in the Neurologists Office: A Nursing Perspective
        Mary Smithson, BSN, MSCN
  5. Mini-Courses
    1. Clinical Trials Management
    2. MRI Insights into MS Pathology
    3. Neurology for the Non-Neurologist
      MS Clinical Syndromes: Lesion Localization and A&P
      Lynn McEwan, RN, MScN, CNNC, MSCN
    4. Botulinum Toxin for the Treatment of Spasticity in MS
    5. Does My Patient Need a Baclofen Pump?
      • ITB Therapy: Medical Issues
        Francois Bethoux, MD
      • ITB Therapy: Nursing Issues
        Danni Gogol, CNS/NP, LPC
      • ITB Therapy and Rehabilitation
        Mathhew Sutliff, PT
    6. Guiding Your Patients Through the World of MS: A Patient Resource Center
      • Benefits of a Patient Resource Center
        Karen Nichols, MEd, CHES
      • Integration into Clinical Practice: Patient Resource Center
        Claire Hara-Cleaver, RN, MSN
    7. Visual Dysfunction in Multiple Sclerosis
      Robert Shin, MD; Janet Rucker, MD; Fiona Costello, MD, FRCP
    8. MS Research Using the CMSC/NARCOMS Database
      Denise Campagnolo, MD; Ruth Ann Marrie, MD; Tuula Tyry, PhD, MAED
  6. Whitaker Track